OUR MISSION

To empower global healthcare ecosystem through innovations

Predicine is a molecular insight company developing genomic profiling tests and robust algorithms for cancer diagnostics and monitoring. Our biology-oriented approach to analyzing genomics is advancing the understanding of tumor mutational landscape.

Our passion

At Predicine, we are passionate about our people, technology, and creating a lasting impact in cancer research. 

 

People

Passionate, fearless and committed talent is our key strength. 35% of our team are PhDs.

 

Technology

We are leading the innovation in urine-based diagnostics.

 

Profound impact

Helping patients worldwide in clinical trials and easy cancer detection.

Our values and culture

Predicine is the culmination of talented people coming together to realize a shared vision. Our culture is dynamic, fast-paced, energetic and innovative. We innovate boldly and have an endless pursuit for quality. We stick by our values to carry out our important roles because we know that the work we do every day impacts real lives.

COMPANY VALUES

  • Integrity
  • Innovation
  • Quality
  • Respect
  • Courage
  • Collaboration
  • Caring
  • Communication

Leadership

Shidong Jia | CEO

Shidong Jia, MD, PhD, is the Founder and CEO of Predicine. Prior to founding Predicine, Shidong spearheaded the oncology biomarker strategies and drug & diagnostics co-development at Genentech. His previous work identified p110beta as novel drug target for PTEN-deficient tumors, a finding that laid the foundation for clinical development and testing of p110beta inhibitors in cancers. He previously held various senior research positions focusing on translational and clinical cancer research at Novartis Institutes for BioMedical Research and Harvard University. Shidong was awarded the P.A.R.T. Investigatorship Award from the Dana-Farber Cancer Institute. Shidong holds a MD and PhD from Harbin Medical University and Peking Union Medical College, and completed postdoctoral training at the Dana-Farber Cancer Institute – Harvard University.

Pan Du | President

Pan Du, PhD, is the Co-founder, President and CTO at Predicine. Pan is an expert in next-generation sequencing, bioinformatics, and oncology diagnostics. He has developed multiple widely used bioinformatics analysis software and has authored numerous publications, including several 1st authorship manuscripts that are cited over thousands times. Prior to Predicine, Pan was Principal Scientist at Roche Diagnostics and Senior Computational Biologist at Genentech. He was previously an Assistant Professor at Biomedical Informatics Center at Northwestern University. Pan holds a PhD with distinction in both Bioinformatics and Electrical Engineering from Iowa State University.

Jianjun Yu | CSO

Jianjun Yu, PhD, is the Chief Scientific Officer at Predicine. Prior to Predicine, Jianjun held various senior bioinformatics positions at Medivation, Genentech and Novartis. Jianjun is an expert in cancer genomics, target discovery & validation, clinical trial and biomarker development. He has authored numerous publications in New England Journal of Medicine and Cancer Cell, Nature, and Science. Jianjun holds a PhD in Bioinformatics from University of Michigan and a BS in Environmental Biology from Peking University.

CAREERS

Join the fight against cancer

If you enjoy challenges, collaborating with others to solve complex problems, and the chance to see your work impact the millions of lives touched by cancer, this is the place to be.

PERKS

• Healthy catered lunches
• Premium snacks and beverages
• Ample employee parking
• Happy hours and quarterly team building events 
• Close to 92 Bridge, easy access to HWY 880

Open Positions

News & Events

LABORATORY

Our molecular genetics lab

We have a CAP-accredited and CLIA-certified laboratory in Hayward, California that uses the most cutting-edge technologies and instruments including Illumina MiniSeq™, Illumina NextSeq™, and Illumina NovaSeq™ 6000 System.   Our high-caliber laboratory staff bring a wealth of sequencing and sample expertise to ensure accuracy and reliability of results.

 

Predicine’s licenses and accreditations:

  • CAP Accreditation: 8169662
  • CLIA Certificate: 05D2148483
  • State of Maryland: 2906
  • State of Pennsylvania: 36601
  • State of Rhode Island: LCO001259
  • State of California: CFD00351747

 

Contact us

If you have any questions or need assistance, our customer support team is on-hand to help.

FAX

+1-650-332-9181

ADDRESS

3555 Arden Road
Hayward, CA 94545, USA

ADDRESS

1698 Wangyuan Road, Building 11
Shanghai, 201499, China

Get in touch

We would love to hear from you. Please use the form below to submit your questions, comments, or inquries about potential partnerships.